These interviews were conducted at the 2019 BioProcess International European Summit in Vienna, Austria. The BPI EU TV program was a combined effort of BioProcess International magazine and KNect365 Life Sciences, both of which are business units within Informa's Knowledge & Networking division.

Viral safety: Hepatitis E's threat to the blood supply - Maria Farcet, Associate Director, Global Pathogen Safety at Takeda speaks with Andy Burrows, BPI TV

Viral safety in cell and gene therapies - Thomas R. Kreil, Vice President of Global Pathogen Safety at Takeda speaks with Andy Burrows, BPI TV

Biologics discovery and development - Dr. Helge Schnerr, Marketing Manager EMEA at Fortébio speaks with Andy Burrows, BPI TV

Building predictive models for bioprocesses - Joey Studts, Global BioProcess and Pharmaceutical Development at Boehringer Ingelheim speaks with Dan Stanton, Editor, BioProcess Insider

How Janssen are using Solentim's Verified In-Situ Plate Seeding instrument - Angela Tuckowski, Associate Scientist at Janssen Pharmaceuticals speaks with Brian Caine, Publisher, BioProcess International

A joint audit model for single-use bioprocessing systems -  James Fries, CEO at consortium Rx-360 speaks with Dan Stanton, Editor, BioProcess Insider

Check out the BPI TV interviews at BPI West 2019 now.

Stay tuned for BPI TV from BWB 2019.